A Novel Variant in the <i>NCF2</i> Gene Causing Autosomal Recessive Chronic Granulomatous Disease: Report of Two Unrelated Paraguayan Families

Introduction Chronic granulomatous disease (CGD) is an inborn error of immunity (IEI) characterized by severe and recurrent infections resulting from defects in the NADPH oxidase complex, which impairs neutrophil function. Mutations in NCF2, which encodes the cytosolic component p67-phox, lead to autosomal recessive (AR) CGD. We describe a novel NCF2 variant identified in two unrelated patients with a clinical phenotype consistent with CGD. Methods As part of a national project to strengthen IEI diagnosis in Paraguay (2022–2024), we evaluated 115 children with recurrent infections. Forty-two patients with suggestive immunological findings underwent whole exome sequencing, supported by the Jeffrey Modell Foundation. In 17 cases, known pathogenic variants associated with IEI were identified. Additionally, a novel variant associated with AR-CGD was detected and confirmed by Sanger sequencing. Functional evaluation included in silico prediction tools and the dihydrorhodamine (DHR) assay. Results The patients—a 6-year-old girl and an 8-year-old boy—were born to non-consanguineous, unrelated parents. Both presented with recurrent pneumonia and lymphadenitis; the boy had prior pulmonary tuberculosis and the girl developed pulmonary sepsis and digital necrosis requiring amputation. Both were homozygous for the NCF2 NM_000433.4:c.338G&amp;gt;A (p.Gly113Glu) variant. Their parents were heterozygous carriers. Although classified as a variant of uncertain significance (VUS) per American College of Medical Genetics and Genomics/Association for Molecular Pathology criteria, in silico analyses predicted high pathogenicity. Routine immunological workups were normal; however, both patients had abnormal DHR test results (stimulation index 60). Conclusion Clinical, genetic, and functional evidence supports the diagnosis of AR-CGD caused by this novel NCF2 variant. This finding expands the mutational spectrum of the NCF2 gene and underscores the importance of genetic analysis in diagnosing IEIs.

Authors

Institutions

Publication Details

Journal
Journal of Human Immunity
Published
2025-12-22
DOI
https://doi.org/10.70962/lasid2025abstract.16
Primary Topic
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel Variant in the NCF2 Gene Causing Autosomal Recessive Chronic Granulomatous Disease: Report of Two Unrelated Paraguayan Families

Diana Sanabria, Ana Godoy, Sara Benegas, Ana Ayala et al.
Journal of Human Immunity
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
article

A Novel Variant in the NCF2 Gene Causing Autosomal Recessive Chronic Granulomatous Disease: Report of Two Unrelated Paraguayan Families

Diana Sanabria, Ana Godoy, Sara Benegas, Ana Ayala, Celia Martínez de Cuéllar, Valerie Joly, Lady Franco
article en

Abstract

Introduction Chronic granulomatous disease (CGD) is an inborn error of immunity (IEI) characterized by severe and recurrent infections resulting from defects in the NADPH oxidase complex, which impairs neutrophil function. Mutations in NCF2, which encodes the cytosolic component p67-phox, lead to autosomal recessive (AR) CGD. We describe a novel NCF2 variant identified in two unrelated patients with a clinical phenotype consistent with CGD. Methods As part of a national project to strengthen IEI diagnosis in Paraguay (2022–2024), we evaluated 115 children with recurrent infections. Forty-two patients with suggestive immunological findings underwent whole exome sequencing, supported by the Jeffrey Modell Foundation. In 17 cases, known pathogenic variants associated with IEI were identified. Additionally, a novel variant associated with AR-CGD was detected and confirmed by Sanger sequencing. Functional evaluation included in silico prediction tools and the dihydrorhodamine (DHR) assay. Results The patients—a 6-year-old girl and an 8-year-old boy—were born to non-consanguineous, unrelated parents. Both presented with recurrent pneumonia and lymphadenitis; the boy had prior pulmonary tuberculosis and the girl developed pulmonary sepsis and digital necrosis requiring amputation. Both were homozygous for the NCF2 NM_000433.4:c.338G&amp;gt;A (p.Gly113Glu) variant. Their parents were heterozygous carriers. Although classified as a variant of uncertain significance (VUS) per American College of Medical Genetics and Genomics/Association for Molecular Pathology criteria, in silico analyses predicted high pathogenicity. Routine immunological workups were normal; however, both patients had abnormal DHR test results (stimulation index 60). Conclusion Clinical, genetic, and functional evidence supports the diagnosis of AR-CGD caused by this novel NCF2 variant. This finding expands the mutational spectrum of the NCF2 gene and underscores the importance of genetic analysis in diagnosing IEIs.

Journal of Human ImmunityVol. 1(LASID2025)
Ministerio de Salud Pública y Bienestar Social (PY), Universidad Nacional de Asunción (PY)
Good health and well-being
Openalex Percentile: Top 37%
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.